Long A, Rahmaoui A, Rothman KJ, Guinan E, Eisner M, Bradley MS, Iribarren C, Chen H, Carrigan G, Rosén K, Szefler S. Incidence of malignancy in patients with moderate-to-severe asthma treated with or without omalizumab. J Allergy Clin Immunol Pract. 2014 Sep;134(3):560-567.e. doi: 10.1016/j.jaci.2014.02.007
Montserrat-Capdevila J, Godoy P, Marsal JR, Cruz I, Solanes M. Effectiveness of influenza vaccination in preventing hospital admission due to exacerbations of chronic obstructive pulmonary disease. Enferm Infecc Microbiol Clin. 2014 Feb;32(2):70-5. doi: 10.1016/j.eimc.2013.02.009
Smets E, Brogan AJ, Hill A, Adriaenssen I, Sawyer AW, Domingo-Pedrol P, Gostkorzewicz J, Ledesma F. Comparative cost-effectiveness analysis between darunavir/ritonavir and other protease inhibitors in treatment-naive human immunodeficiency syndrome type 1-infected patients in Spain. Enferm Infecc Microbiol Clin. 2013 Aug;31(7):430-6.
Serna MC, Real J, Ribes E, Marsal JR, Godoy P, Galvin L. Factors determining antibiotic prescription in primary care. Enferm Infecc Microbiol Clin. 2011 Mar;29(3):193-200. doi: 10.1016/j.eimc.2010.09.012
Hirst C, Castellsague J, Calingaert B, Stanford RH. Asthma exacerbations associated with inhaled corticosteroid/long-acting beta-agonists or other inhaled corticosteroid regimens in pediatrics: meta-analysis of observational studies. J Allergy Clin Immunol Pract. 2010 Feb 1;125(2):AB71.
Arellano FM, Arana A, Wentworth CE, Fernández-Vidaurre C C, Schlienger RG, Conde E. Lymphoma among patients with atopic dermatitis and/or treated with topical immunosuppressants in the United Kingdom. J Allergy Clin Immunol Pract. 2009;123(5):111-6-116.
Santanello NC, Demuro-Mercon C, Davies G, Ostrom N, Noonan M, Rooklin A, Knorr B. Validation of a pediatric asthma caregiver diary. J Allergy Clin Immunol Pract. 2000 Nov 1;106(5):861-6.